Chronic Fatigue Syndrome Market Boosted by Diagnostic Advancements and Research Funding | Hemispherx Biopharma, Inc., Torrent Pharmaceuticals Ltd., Fortis Healthcare

The global Chronic fatigue syndrome Market size was valued USD 70.93 billion in 2024, and is estimated to reach USD USD 130.1 billion by 2033, growing at a CAGR of 11.2% during the forecast period (2025-2033).

Chronic Fatigue Syndrome Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With increasing recognition of ME/CFS, ongoing biomarker research, and heightened patient advocacy, the report delivers strategic insights for stakeholders in chronic and rare disease management from 2025 to 2033.

In Japan, a longitudinal hospital-based study found that the prevalence of long COVID-induced ME/CFS declined notably from 23.9% in early pandemic patients to 3.3% among those infected during the Omicron wave highlighting the evolving trends of post-viral fatigue syndromes. Meanwhile, population-based data revealed a CFS prevalence of approximately 0.76% in Japan, comparable to rates in South Korea, underscoring a consistent disease burden across the region

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/chronic-fatigue-syndrome-market?ophp

The CFS market focuses on symptom management through lifestyle interventions, cognitive behavioral therapy, and pharmacological options, as no cure exists. Market growth is supported by increasing research into post-viral fatigue syndromes and greater recognition of the condition in clinical practice.

Chronic fatigue syndrome Market Competitors Overview:

Hemispherx Biopharma, Inc., Torrent Pharmaceuticals Ltd., Fortis Healthcare, F. Hoffmann-La Roche Ltd, K-PAX Pharmaceuticals, Inc., Dr Batra's, London School of Hygiene L, Tropical Medicine - CureME.

Important Industry Updates:

On June 11, 2021. There has been increasing evidence supports the role of genetic susceptibility in patients with CFS. Family history studies of chronic fatigue syndrome have shown significantly higher family members rates of the patient reporting CFS or similar fatigue-like symptoms.

Methodology and Scope

The Chronic fatigue syndrome Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/chronic-fatigue-syndrome-market?ophp

Chronic fatigue syndrome Market Segments Overview:

By Type (Immune Enhancer & Antivirals, Sleep Enhancing, CNS Stimulants, Others), By End-User (Hospitals, Clinics, Research Institutes)

Regional Overview for Chronic fatigue syndrome Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=chronic-fatigue-syndrome-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Chronic fatigue syndrome market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Chronic fatigue syndrome market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.